Your browser doesn't support javascript.
loading
Expression of Cathepsins B, D, and G in WHO Grade I Meningioma.
Rahman, Rosanna M A; van Schaijik, Bede; Brasch, Helen D; Marsh, Reginald W; Wickremesekera, Agadha C; Johnson, Reuben; Woon, Kelvin; Tan, Swee T; Itinteang, Tinte.
Afiliação
  • Rahman RMA; Gillies McIndoe Research Institute, Wellington, New Zealand.
  • van Schaijik B; Department of Neurosurgery, Wellington Regional Hospital, Wellington, New Zealand.
  • Brasch HD; Gillies McIndoe Research Institute, Wellington, New Zealand.
  • Marsh RW; Gillies McIndoe Research Institute, Wellington, New Zealand.
  • Wickremesekera AC; Gillies McIndoe Research Institute, Wellington, New Zealand.
  • Johnson R; Faculty of Medicine, Auckland University, Auckland, New Zealand.
  • Woon K; Gillies McIndoe Research Institute, Wellington, New Zealand.
  • Tan ST; Department of Neurosurgery, Wellington Regional Hospital, Wellington, New Zealand.
  • Itinteang T; Department of Neurosurgery, Wellington Regional Hospital, Wellington, New Zealand.
Front Surg ; 6: 6, 2019.
Article em En | MEDLINE | ID: mdl-30949483
ABSTRACT

Aim:

We have recently demonstrated the presence of putative tumor stem cells (TSCs) in World Health Organization (WHO) grade I meningioma (MG) localized to the microvessels, which expresses components of the renin-angiotensin system (RAS). The RAS is known to be dysregulated and promotes tumorigenesis in many cancer types, including glioblastoma. Cathepsins B, D, and G are isoenzymes that catalyze the production of angiotensin peptides, hence providing bypass loops for the RAS. This study investigated the expression of cathepsins B, D, and G in WHO grade I MG in relation to the putative TSC population we have previously demonstrated.

Methods:

3,3-Diaminobenzidine (DAB) immunohistochemical (IHC) staining with antibodies for cathepsins B, D, and G was performed on WHO grade I MG tissue samples from 10 patients. Three of the MG samples subjected to DAB IHC staining underwent immunofluorescence (IF) IHC staining to investigate co-expression of each of these cathepsins using combinations of smooth muscle actin (SMA) and embryonic stem cell marker OCT4. NanoString mRNA expression (n = 6) and Western blotting (WB; n = 5) analyses, and enzyme activity assays (EAAs; n = 3), were performed on snap-frozen WHO grade I MG tissue samples to confirm transcriptional activation, protein expression, and functional activity of these proteins, respectively.

Results:

DAB IHC staining demonstrated expression of cathepsins B, D, and G in all 10 MG samples. NanoString mRNA expression and WB analyses showed transcriptional activation and protein expression of all three cathepsins, although cathepsin G was expressed at low levels. EAAs demonstrated that cathepsin B and cathepsin D were functionally active. IF IHC staining illustrated localization of cathepsin B and cathepsin D to the endothelium and SMA+ pericyte layer of the microvessels, while cathepsin G was localized to cells scattered within the interstitium, away from the microvessels.

Conclusion:

Cathepsin B and cathepsin D, and to a lesser extent cathepsin G, are expressed in WHO grade I MG. Cathepsin B and cathepsin D are enzymatically active and are localized to the putative TSC population on the microvessels, whereas cathepsin G was localized to cells scattered within the interstitium, These results suggest the presence of bypass loops for the RAS, within WHO grade I MG.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article